George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.45
Bid: 11.30
Ask: 11.60
Change: 0.20 (1.72%)
Spread: 0.30 (2.655%)
Open: 11.65
High: 11.80
Low: 11.80
Prev. Close: 11.60
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Diversified Energy offers dividend alternative

Thu, 15th Feb 2024 16:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Forward Partners Group PLC - London-based early-stage technology-focused investor - Announces that the 'change of control' conditions relating to the takeover of the company by Molten Ventures have been satisfied. Explains the scheme by which the takeover will be facilitated is now subject to court approval at a hearing on March 12. Subject to this approval, the scheme is expected to become effective on March 14.

----------

Tekcapital PLC - London-based intellectual property investor - Provides an update on Guident Ltd's strategic partnership with AuVe Tech OU. Guident is a Tekcapital portfolio company. Guident plans to integrate its autonomous vehicle remote monitoring, control, assistance, and passenger support services with the autonomous shuttle, MiCa from Auve Tech. Notes Auve Tech is an Estonia-based company that specializes in the development and manufacturing of autonomous transportation systems.

----------

Sovereign Metals Ltd - Malawi-focused mining exploration and development company - Appoints Marco Da Cunha, as its new lead environmental, social and governance officer. Notes Da Cunha has almost 20 years of experience in the field of environmental and social management.

----------

Tower Resources PLC - Africa-focused oil and gas company - Reaches agreement for the repayment of the outstanding balance owed to Energy Exploration Capital Partners, LLC in accordance with the terms announced on January 16, 2023. Further, announces subscription for around 3.33 billion shares at 0.018 pence each. Explains this will raise GBP600,000 which will fund working capital, including the repayment to EECP. Funds will also help progress work on the company's licenses; including the Thali PSC, offshore Cameroon, PEL 96 in Namibia, and the Algoa-Gamtoos license in South Africa. Tower Resources says the subscription will be issued in two tranches with a first tranche of 1.05 billion shares and a second tranche of 2.29 billion shares.

----------

Power Metal Resources PLC - exploration company focused on North America, Africa, and Australia - Issues update concerning its uranium property portfolio focused on the Athabasca Basin area in Saskatchewan, Canada. Says the newly acquired Richards Lake Uranium Property was staked during the most recent mineral administration registry Saskatchewan electronic registry system claim. Power Metals points out the Richards Lake acquisition takes the company's uranium portfolio to eighteen properties.

----------

Poolbeg Pharma PLC - London-based clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Says Cathal Friel, co-founder, substantial shareholder, and currently non-executive chair, will become executive chair effective immediately. Friel says: "I believe Poolbeg is well positioned for success. As part of my ongoing commitment to the company, I also intend to start increasing my shareholding in Poolbeg as and when I am able to do so". Further, company launches employee incentive performance plan. Friel says this will "incentivise and retain key members of the Poolbeg management team."

----------

Diversified Energy Company PLC - Alabama, US-based oil and gas production company - Intends to offer shareholders two options with regard to payment of the dividend announced in November. Shareholders can either receive the dividend on March 28 as normal. Or, they can waive some or all of the payout in order to have their shares purchased in a tender offer for cash. Explains the tender price will include a premium. Diversified Energy believes that the current share price does not reflect the quality of the assets nor the significant opportunities for its long-term strategy. Therefore, considers the repurchase of shares a prudent use of capital and in the best interests of the shareholders. Plans to fund the tender offer from existing resources.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:10

Poolbeg Pharma to be granted US patent

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Read more
19 Feb 2024 14:22

Director dealings: Poolbeg Pharma co-founder ups stake

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Read more
12 Feb 2024 19:44

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
12 Feb 2024 14:37

Poolbeg upbeat on research into potential drug market

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced findings from independent research confirming a substantial market opportunity exceeding $10bn for its drug candidate POLB 001 on Monday, in preventing cancer immunotherapy-induced cytokine release syndrome (CRS) through oral delivery.

Read more
17 Jan 2024 13:58

Poolbeg Pharma hails POLB 001'S potential to treat CRS

(Alliance News) - Poolbeg Pharma PLC on Wednesday noted "promising" results for POLB 001's potential in treating cancer immunotherapy-induced cytokine release syndrome.

Read more
20 Dec 2023 20:00

TRADING UPDATES: K3 Business says cash balances ahead of forecast

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Dec 2023 13:54

Poolbeg makes promising progress with RSV programme

(Sharecast News) - Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.

Read more
21 Nov 2023 14:39

TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
9 Nov 2023 16:57

IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team

Poolbeg Pharma PLC - Clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need - Appoints a number of former executives of Amryt Pharma PLC to its leadership team. Poolbeg's Chair, Cathal Friel, co-founded both Poolbeg and Amryt Pharma.

Read more
17 Oct 2023 10:49

Poolbeg Pharma shares up on metabolic drug collaboration agreement

(Alliance News) - Poolbeg Pharma PLC on Tuesday said it has agreed to collaborate with an unnamed Nasdaq-listed biopharmaceutical company for the development of an optimised oral drug to treat a metabolic condition.

Read more
2 Oct 2023 14:20

EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week and not separately reported by Alliance News:

Read more
22 Sep 2023 20:37

TRADING UPDATES: Braemar investigation to end; Marula reports delay

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately reported by Alliance News:

Read more
20 Sep 2023 12:16

Poolbeg gets notice of a new Japan patent

(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma announced the receipt of a notice of allowance from the Japanese Patent Office for its Immunomodulator I patent application on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.